Back to Search Start Over

Comparison of Three Escherichia coli Strains in Recombinant Production of Reteplase

Authors :
Fathi-Roudsari, Mehrnoosh
Akhavian-Tehrani, Asal
Maghsoudi, Nader
Source :
Avicenna Journal of Medical Biotechnology
Publication Year :
2016
Publisher :
Avicenna Research Institute, 2016.

Abstract

Background: Escherichia coli (E. coli) is the most extensively used host for the production of recombinant proteins. However, most of the eukaryotic proteins are typically obtained as insoluble, misfolded inclusion bodies that need solubilization and refolding. Reteplase as a highly disulfide-bonded recombinant protein is an example of difficult to express protein in E. coli. Methods: In this study, a codon optimized reteplase gene was synthetically prepared and cloned under the control of an IPTG inducible T7 promoter. The vector was simultaneously transformed and expressed in three different E. coli strains. The ability of strains for expression of this recombinant pharmaceutical was compared. Also, an attempt was made to increase the soluble production of reteplase in SHuffle T7 E. coli with alterations of expression condition like temperature, inducer concentration and oxygen supply. Results: High amounts of reteplase were expressed as inclusion bodies in all three strains. BL21 (DE3) showed the highest level of expression in inclusion bodies followed by Rosetta-gami (DE3) and Shuffle T7. Changes of expression conditions were insufficient for soluble expression of reteplase in SHuffle T7 as a genetically engineered host for production of disulfide bonded proteins. Conclusion: The oxidizing cytoplasm of Rosetta-gami and Shuffle T7 in addition to alterations of cultivation parameters could not result in soluble production of reteplase, although the inclusion bodies produced in these two strains might increase the rate of refolding procedure likely due to formation of folding intermediates.

Details

Language :
English
ISSN :
20084625 and 20082835
Volume :
8
Issue :
1
Database :
OpenAIRE
Journal :
Avicenna Journal of Medical Biotechnology
Accession number :
edsair.pmid..........d0b1ff9ab05000a1f380d9d9659be278